Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma

Alexander M M Eggermont, Stefan Suciu, Alessandro Testori, Mario Santinami, Wim H J Kruit, Jeremy Marsden, Cornelis J A Punt, François Salès, Reinhard Dummer, Caroline Robert, Dirk Schadendorf, Poulam M. Patel, Gaetan De Schaetzen, Alan Spatz, Ulrich Keilholz

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences